. Author manuscript; available in PMC: 2019 May 1.

Published in final edited form as: Hepatology. 2018 Mar 26;67(5):1931–1942. doi: 10.1002/hep.29694

Table 5.

Relationship between transfusion of RBC, plasma, or platelets between days 1–7 to outcome of ALF at day 21.

Treatment During Inpatient (Day 1–7)	Outcome at Day 21
	Spontaneous Survivors (N=713) N (%)	Non-Spontaneous Survivors (NSS)			P^*
	Spontaneous Survivors (N=713) N (%)	All NSS (N=944) N (%)	Liver Transplantation (N=430) N (%)	Death (N=599) N (%)	P^*
Vitamin K	152(20%)	143(15%)	54(13%)	92(15%)	0.006
rVIIa	9(1.2%)	28(2.8%)	16(4%)	13(2%)	0.022
RBC Transfusion	207(27%)	444(45%)	197(46%)	278(46%)	< 0.001
Plasma Transfusion	302(39%)	692(70%)	312(73%)	415(69%)	< 0.001
Platelet Transfusion	122(16%)	313(32%)	141(33%)	192(32%)	< 0.001

p-value compares probability of receiving the indicated treatment between spontaneous survivors and subjects who either received a liver transplant and/or died.